Abstract
Background/aims: The offer of human saliva IGF-I (sIGF-I) measurement in athletes investigation is a new proposal. The aim was to investigate the physical exercise effect on sIGF-I and explore plasma free IGF-I relation. Materials and methods: Saliva and blood were collected from well-trained athletes, investigated immediately before and at the end of a physical exercise test. Results: sIGF-I was significantly increased at the end of the physical exercise. The plasma free IGF-I concentrations did not demonstrate any difference. The saliva total protein level (sTP) was also significantly increased. A positive correlation between sTP and sIGF-I, was observed, both before and after physical exercise, and between salivary and plasma free IGF-I only after physical exercise. The salivary free IGF-I level significantly increased after physical exercise, moreover a correlation with the plasma levels exists in post-exercise condition. Conclusion: The physical exercise affects sIGF-I as well as the sTP. The correlation between plasma and salivary free IGF-I levels only in post-exercise condition suggests further studies to investigate the effects of different type and duration of physical exercise. The comparison with other salivary biochemical parameter investigation would also further increase comprehension on the role of salivary IGF-I.
Similar content being viewed by others
References
Le Roith D, Bondy C, Yakar S, Liu JL, Butler A. The somatomedin hypothesis: 2001. Endocr Rev 2001, 22: 53–74.
Stokes K. Growth hormone responses to sub-maximal and sprint exercise. Growth Horm IGF Res 2003, 13: 225–38.
De Palo EF, Gatti R, Lancerin F, Cappellin E, Spinella P. Correlations of growth hormone (GH) and insulin-like growth factor I (IGF-I): effects of exercise and abuse by athletes. Clin Chim Acta 2001, 305: 1–17.
Berg U, Bang P. Exercise and circulating insulin-like growth factor I. Horm Res 2004, 62(Suppl 1): 50–8.
De Palo EF, Gatti R, Lancerin F, Cappellin E, De Palo CB, Spinella P. Urinary insulin-like growth factor-I measurement in an actual sport competition, an additional approach in laboratory antidoping tests. Clin Chim Acta 2005, 351: 73–8.
Rubin MR, Kraemer WJ, Maresh CM, et al. High-affinity growth hormone binding protein and acute heavy resistance exercise. Med Sci Sports Exerc 2005, 37: 395–403.
Ehrnborg C, Lange KH, Dall R, et al; GH-2000 Study Group. The growth hormone/insulin-like growth factor-I axis hormones and bone markers in elite athletes in response to a maximum exercise test. J Clin Endocrinol Metab 2003, 88: 394–401.
Kraemer RR, Durand RJ, Acevedo EO, et al. Rigorous running increases growth hormone and insulin-like growth factor-I without altering ghrelin. Exp Biol Med 2004, 229: 240–6.
Nemet D, Connolly PH, Pontello-Pescatello AM, et al. Negative energy balance plays a major role in the IGF-I response to exercise training. J Appl Physiol 2004, 96: 276–82.
Rosendal L, Langberg H, Flyvbjerg A, Frystyk J, Ørskov H, Kjaer M. Physical capacity influences the response of insulin-like growth factor and its binding proteins to training. J Appl Physiol 2002, 93: 1669–75.
Walker KS, Kambadur R, Sharma M, Smith HK. Resistance training alters plasma myostatin but not IGF-I in healthy men. Med Sci Sports Exerc 2004, 36: 787–93.
Nindl BC, Kraemer WJ, Marx JO, et al. Overnight responses of the circulating IGF-I system after acute, heavy-resistance exercise. J Appl Physiol 2001, 90: 1319–26.
Kraemer WJ, Hatfield DL, Spiering BA, et al. Effects of a multi-nutrient supplement on exercise performance and hormonal responses to resistance exercise. Eur J Appl Physiol 2007, 101: 637–46.
Kaplan SA, Cohen P. The somatomedin hypothesis 2007: 50 years later. J Clin Endocrinol Metab 2007, 92: 4529–35.
Binoux M. The IGF system in metabolism regulation. Diabete Metab 1995, 21: 330–7.
Duan C, Xu Q. Roles of insulin-like growth factor (IGF) binding proteins in regulating IGF actions. Gen Comp Endocrinol 2005, 142: 44–52.
Antonelli G, Cappellin E, Gatti R, Chiappin S, Spinella P, De Palo EF. Measurement of free IGF-I saliva levels: perspectives in the detection of GH/IGFaxis in athletes. Clin Biochem 2007, 40: 545–50.
Chiappin S, Antonelli G, Gatti R, De Palo EF. Saliva specimen: a new laboratory tool for diagnostic and basic investigation. Clin Chim Acta 2007, 383: 30–40.
Helmerhorst EJ, Oppenheim FG. Saliva: a dynamic proteome. J Dent Res 2007, 86: 680–93.
Dereka XE, Markopoulou CE, Vrotsos. Role of growth factors on peridontal repair. Growth Factors 2006, 26: 260–7.
Zelles T, Purushotham KR, Macauley SP, Oxford GE, Humphreys-Beher MG. Saliva and growth factors: the fountain of youth resides in us all. J Dent Res 1995, 74: 1826–32.
Werner H, Katz J. The emerging role of the insulin-like growth factors in oral biology. J Dent Res 2004, 83: 832–6.
Lewis JG. Steroid analysis in saliva: an overview. Clin Biochem Rev 2006, 27: 139–46.
López Calbet JA, Navarro MA, Barbany JR, Garcia Manso J, Bonnin MR, Valero J. Salivary steroid changes and physical performance in highly trained cyclists. Int J Sports Med 1993, 14: 111–7.
Kniess A, Ziegler E, Kratzsch J, Thieme D, Müller RK. Potential parameters for the detection of hGH doping. Anal Bioanal Chem 2003, 376: 696–700.
McHugh CM, Park RT, Sönksen PH, Holt RI. Challenges in detecting the abuse of growth hormone in sport. Clin Chem 2005, 51: 1587–93.
Holt RI, Sönksen PH. Growth hormone, IGF-I and insulin and their abuse in sport. Br J Pharmacol 2008, 154: 542–56.
Tentori L, Graziani G. Doping with growth hormone/IGF-1, anabolic steroids or erythropoietin: is there a cancer risk? Pharmacol Res 2007, 55: 359–69.
Ryan J, Mantle T, Costigan DC. A normal population study of human salivary insulin-like growth factor 1 (IGF 1) concentrations from birth through puberty. J Clin Endocrinol Metab 1992, 74: 774–8.
Halimi S, Tepavcevic D, Suchanek D, Giljevic Z, Palvsic V, Korsic M. Measurement of salivary insulin-like growth factor-I in acromegaly: comparison with serum insulin-like growth factor-I and growth hormone concentrations. Eur J Clin Chem Clin Biochem 1994, 32: 705–7.
Costigan DC, Guyda HJ, Posner BI. Free insulin-like growth factor I (IGF-I) and IGF-II in human saliva. J Clin Endocrinol Metab 1988, 66: 1014–8.
Shpitzer T, Bahar G, Feinmesser R, Nagler RM. A comprehensive analysis for oral cancer diagnosis. J Cancer Res Clin Oncol 2007, 133: 613–7.
Chicharro JL, Lopez-Calderon A, Hoyos J, et al. Effects of an endurance cycling competition on resting serum insulin-like growth factor I (IGF-I) and its binding proteins IGFBP-1 and IGFBP-3. Br J Sports Med 2001, 35: 303–7.
Hall K, Hilding A, Thorén M. Determinants of circulating insulin-like growth factor-I. J Endocrinol Invest 1999, 22(Suppl): 48–57.
Jørgensen JO, Christensen JJ, Krag M, Fisker S, Ovesen P, Christiansen JS. Serum insulin-like growth factor I levels in growth hormone-deficient adults: influence of sex steroids. Horm Res 2004, 62(Suppl 1): 73–6.
Ryan J, Mantle T, McQuaid S, Costigan DC. Salivary insulin-like growth factor-I originates from local synthesis. J Endocrinol 1992, 135: 85–90.
De Palo EF, Gatti R, Lancerin F, et al. Effects of acute, heavy-resistance exercise on urinary peptide hormone excretion in humans. Clin Chim Lab Med 2003, 41: 1308–13.
Ljungberg G, Ericson T, Ekblom B, Birkhed D. Saliva and marathon running. Scand J Med Sci Sports 1997, 7: 214–9.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Antonelli, G., Gatti, R., Prearo, M. et al. Salivary free Insulin-like Growth Factor-I levels: Effects of an acute physical exercise in athletes. J Endocrinol Invest 32, 1–5 (2009). https://doi.org/10.1007/BF03345669
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03345669